“News neutrality by unbiased coverage”
One News Page
"Lung Cancer" News 

Epigenomics AG: Centers for Medicare & Medicaid Services publish final rate of $192 for Epigenomics' colorectal cancer screening blood test Epi proColon(R)

DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 22.10.2018 / 07:33 The issuer is solely responsible for the content of this announcement. -------------------- Press..
Credit: EQS Group - Published

G1 Therapeutics Presents Additional Data from Randomized Phase 2 Trial of Trilaciclib in Combination with Etoposide/Carboplatin for Treatment of First-Line Small Cell Lung Cancer

· New data analyses highlight myelopreservation and immune system benefits of trilaciclib in combination with chemotherapy · Data presented at the European Society for Medical Oncology (ESMO) 2018..
Credit: GlobeNewswire - Published

Videos for "Lung Cancer"

Health Beat: Checkmate for prostate cancer [Video]Health Beat: Checkmate for prostate cancer 

Health Beat: Checkmate for prostate cancer

Credit: WFMZ Allentown, PA - Published

Medical Breakthroughs - Detecting lung cancer earlier [Video]Medical Breakthroughs - Detecting lung cancer earlier 

Lung cancer kills more Americans than breast, prostate and colon cancer combined, and like other forms of cancer, the earlier it's caught the better chance patients have to survive.

Credit: WKBT - Published

New Hope for Lung Cancer Survival [Video]New Hope for Lung Cancer Survival  03:00

New Hope To extend survival for certain patient with stage 3 lung cancer for first time in a decade

Credit: Rumble - Published

New 'GPS' For Tumors Offers New Hope For Patients [Video]New 'GPS' For Tumors Offers New Hope For Patients  02:56

There’s a new way to do radiation therapy for lung cancer that spares normal lung tissue while hitting the tumor with fatal doses of radiation. CBS2's Dr. Max Gomez reports.

Credit: CBS 2 New York - Published

IRONMAN World Championship Racer Is Woman W/ Stage IV Lung Cancer [Video]IRONMAN World Championship Racer Is Woman W/ Stage IV Lung Cancer  00:35

Isabella de la Houssaye, a woman with stage IV lung cancer, completed this year's IRONMAN World Championship. Only six months after her diagnosis she swam 2.4 miles, biked 112, and ran a marathon. The..

Credit: Wochit - Published

Fifth Grader Runs 50 5K's In 50 Days For Grandpa's Lung Cancer [Video]Fifth Grader Runs 50 5K's In 50 Days For Grandpa's Lung Cancer  02:33

It all began when ten-year-old Niall McDermott watched a movie about a man called the "Iron Cowboy" who completed 50 triathlons in 50 days and was inspired. John Ramos reports. (10-14-2018)

Credit: CBS 5 SF KPIX - Published


Loxo Oncology Announces Larotrectinib Clinical Update in Patients with TRK Fusion Cancers at the European Society for Medical Oncology 2018 Congress

- Median Duration of Response Not Reached With One Year of Additional Follow-up - - 67 Newly Reported TRK Fusion Patients Exhibit 81% ORR - STAMFORD, Conn., Oct. 21, 2018 (GLOBE NEWSWIRE) -- Loxo..
Credit: GlobeNewswire - Published

Roche's investigational personalised medicine entrectinib shrank tumours in people with NTRK fusion-positive solid tumours

· *Entrectinib showed response irrespective of tumour type or spread to the central nervous system (CNS)* · *Data will be submitted to global regulatory authorities, including the US Food and Drug..
Credit: GlobeNewswire - Published

US Air Pollution Deaths Nearly Halved Between 1990 And 2010

Air pollution in the U.S. has decreased since about 1990, and a new study conducted at the University of North Carolina at Chapel Hill now shows that this air quality improvement has brought..
Credit: Eurasia Review - Published

Roche's Tecentriq in combination with Abraxane improves outcomes as an initial treatment for people with PD-L1-positive metastatic triple-negative breast cancer

· *Tecentriq combination first immunotherapy regimen to demonstrate positive Phase III results in breast cancer * · *Tecentriq and nab-paclitaxel significantly reduced the risk of disease worsening..
Credit: GlobeNewswire - Published

TESARO Announces Data Presentations at ESMO 2018 Congress

· *Data presented indicate that TSR-042 (anti-PD-1 antibody) is well tolerated and has robust activity in patients with MSI-H endometrial cancer* · *PRIMA safety data for individualized niraparib..
Credit: GlobeNewswire - Published

WMIC 2018 Young Investigator of the Year Awarded to Caltech’s Dr. George J. Lu for Research in Combining MRI and Ultrasound Technologies

The World Molecular Imaging Society (WMIS) is dedicated to empowering the next generation of scientists and is proud to present this year’s Young Investigator Award to George J. Lu, Ph.D., California..
Credit: PRWeb - Published

FDA extends action date to May 2019 for Bristol-Myers Squibb's Opdivo + Yervoy in 1st line lung cancer

Credit: SeekingAlpha - Published

Bristol-Myers Squibb Provides Update on the Ongoing Regulatory Review of Opdivo Plus Low-Dose Yervoy in First-Line Lung Cancer Patients with Tumor Mutational Burden ≥10 mut/Mb

bristol-myers squibb provides update on the ongoing regulatory review of opdivo plus low-dose yervoy in first-line lung cancer patients with tumor mutational burden ≥10 mut/mb
PRINCETON, N.J.--(BUSINESS WIRE)--$BMY #BMS--Bristol-Myers Squibb Provides Update on the Ongoing Regulatory Review of Opdivo Plus Low-Dose Yervoy in First-Line Lung Cancer Patients with...
Credit: Business Wire - Published

AstraZeneca launches new study to investigate lung cancer resistance mechanisms to Tagrisso

Credit: SeekingAlpha - Published

NANOBIOTIX: Positive phase II/III results for NBTXR3 in Soft Tissue Sarcoma presented at ESMO

** *NANOBIOTIX: POSITIVE PHASE II/III RESULTS FOR NBTXR3 IN SOFT TISSUE SARCOMA PRESENTED AT ESMO* · *Dr. Sylvie Bonvalot, Head of Sarcoma and Complex Tumor Surgery Unit at Institut Curie -..
Credit: GlobeNewswire - Published

Takeda's Alunbrig beats Pfizer's Xalkori in first-line lung cancer study

Credit: SeekingAlpha - Published

Incyte's capmatinib shows positive action in mid-stage lung cancer study; shares ahead 2%

Credit: SeekingAlpha - Published

Novartis phase II GEOMETRY mono-1 trial of investigational medicine capmatinib (INC280) shows positive results in patients with MET mutated advanced NSCLC

· Phase II study efficacy data showed overall response rate of 72.0% and 39.1%, respectively, in treatment-naive and previously treated patients with advanced MET exon-14 skipping mutated non-small..
Credit: GlobeNewswire - Published

Merrimack Pharmaceuticals shares tumble on termination of Phase 2 trial for lung cancer treatment

Shares of Merrimack Pharmaceuticals Inc (NASDAQ:MACK) plunged in Friday’s pre-market session after the clinical-stage oncology company announced it terminated a Phase 2 trial for its treatment of..
Credit: Proactive Investors - Published

Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer

takeda to present results from phase 3 alta-1l trial highlighting intracranial efficacy of alunbrig® (brigatinib) versus crizotinib in first-line advanced alk+ non-small cell lung cancer
CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of..
Credit: Business Wire - Published

Aeglea BioTherapeutics to Present Preclinical Data on New Pipeline Therapeutic for Homocystinuria at 2018 American Society of Human Genetics (ASHG) Conference

AEB4104 is a Novel Engineered Human Enzyme with Unique Specificity for Degrading Both Homocysteine and HomocystineAEB4104 Prevents Death, Stops Disease Progression, and Reverses Liver Pathology in a..
Credit: GlobeNewswire - Published

EDGC to Launch Liquid Biopsy Screening Service, Technology for Early Detection of Cancers, This Autumn

edgc to launch liquid biopsy screening service, technology for early detection of cancers, this autumn
· Liquid biopsy drawing attention for preventing the recurrence of cancer and allowing for early detection of cancers · EDGC develops the most advanced lipuid biopsy technology SEOUL, South..
Credit: PR Newswire Asia - Published

BeyondSpring to Host Second-Quarter 2018 Financial Results and Operational Update Conference Call on October 23, 2018

Dr. Douglas Blayney from Stanford University to Join to Discuss Recently Announced Clinical DataNEW YORK, Oct. 19, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global, clinical-stage..
Credit: GlobeNewswire - Published

You Might Like

 Page 1  〉 
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2018 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Contact us  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest